Tag Archives: leukemia

Novartis: European Commission approval for Kymriah

The EC approval is based on the first global CAR-T registration trials, which included patients from eight European countries and demonstrated durable responses and a consistent safety profile in r/r pediatric B-cell ALL and r/rDLBCL Novartis is the only company with an approved … Read the full press release

Novartis: Today’s FDA approval of Kymriah provides another opportunity for Novartis to build on its leadership in CAR-T development

Kymriah demonstrated an overall response rate of 50%, with median duration of response not yet reached at the time of data cut-off, indicating sustainability of response[1] Kymriah is the only CAR-T therapy FDA-approved for two distinct indications – in non-Hodgkin … Read the full press release

Large, randomized Phase III studies demonstrate superiority of Novartis Tasigna® (nilotinib) compared to Glivec® (imatinib) in newly diagnosed Ph+ CML patients

ENESTnd data indicate trend for longer overall survival and event-free survival in newly diagnosed Ph+ CML patients on Tasigna versus Glivec[1] Data demonstrated higher rates of early and deeper molecular response in newly diagnosed patients, including MR4.5, and a reduced … Read the full press release

First Investment Bank Bulgaria supported the charity match “Legends of Bulgaria” – “Aston Villa”

 The charity match is in support of Stiliyan Petrov 29-5-2013 — /europawire.eu/ — Fibank (First Investment Bank) has bought 1,000 tickets for the spectacular beneficial show to take place at “Vasil Levski” national stadium on 26 May. At 15:00 hours, the “Legends … Read the full press release